USD10
FENC Shares
About Fennec PharmaceuticalsFennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
USD10
FENC Shares
About Fennec PharmaceuticalsFennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$364.39M
OPEN PRICE
$10.31
LOW (1Y)
$5.65
HIGH (1Y)
$11.31
LOW (24H)
$10.08
HIGH (24H)
$10.61
VOLUME (24H)
$173.14K
75.59%
Price history
Time | Price | Change |
|---|---|---|
Today | $10.31 | |
1 Day | $10.31 | |
1 Week | $11.01 | |
1 Month | $8.85 | |
1 Year | $8.79 |
Past performance is not a reliable indicator of future results.
Discover more
Popular cryptocurrencies
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.